bibliographicCitation |
Powe DG, Voss MJ, Zänker KS, Habashy HO, Green AR, Ellis IO, Entschladen F. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010 Nov;1(7):628–38. PMID: 21317458; PMCID: PMC3248123. |